415 related articles for article (PubMed ID: 6127351)
1. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.
Stahl SM; Davis KL; Berger PA
J Clin Psychopharmacol; 1982 Oct; 2(5):321-8. PubMed ID: 6127351
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia.
Stahl SM; Yesavage JA; Berger PA
J Clin Psychiatry; 1982 Nov; 43(11):445-6. PubMed ID: 7174619
[TBL] [Abstract][Full Text] [Related]
3. Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions.
Clark GT; Ram S
Dent Clin North Am; 2007 Jan; 51(1):225-43, viii-ix. PubMed ID: 17185068
[TBL] [Abstract][Full Text] [Related]
4. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
Chen JJ; Ondo WG; Dashtipour K; Swope DM
Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
[TBL] [Abstract][Full Text] [Related]
5. Involuntary movement disorders.
Still CN
Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
[TBL] [Abstract][Full Text] [Related]
6. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
Marsden CD
Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
[No Abstract] [Full Text] [Related]
7. Movement disorders in the elderly.
Gilmore R
Geriatrics; 1984 Jun; 39(6):65-8, 72-6. PubMed ID: 6144615
[No Abstract] [Full Text] [Related]
8. Movement disorders: why don't those synapses fire?
Zemlak V; Woldehana A
Axone; 1992 Dec; 14(2):46-9. PubMed ID: 1337267
[TBL] [Abstract][Full Text] [Related]
9. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
10. Therapeutics of disordered movement.
Sears ES
Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204
[TBL] [Abstract][Full Text] [Related]
11. Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
Wray SR; Melville GN; Grell GA; Edge PC
West Indian Med J; 1981 Sep; 30(3):107-18. PubMed ID: 6117153
[No Abstract] [Full Text] [Related]
12. The pathophysiology of movement disorders.
Marsden CD
Neurol Clin; 1984 Aug; 2(3):435-59. PubMed ID: 6241955
[TBL] [Abstract][Full Text] [Related]
13. Tardive dystonia.
Kang UJ; Burke RE; Fahn S
Adv Neurol; 1988; 50():415-29. PubMed ID: 3400500
[TBL] [Abstract][Full Text] [Related]
14. Dystonia.
Korczyn AD; Inzelberg R
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):350-7. PubMed ID: 8507905
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis.
Trugman JM; Leadbetter R; Zalis ME; Burgdorf RO; Wooten GF
Mov Disord; 1994 Jul; 9(4):441-6. PubMed ID: 7969212
[TBL] [Abstract][Full Text] [Related]
16. New nomenclature for drug-induced movement disorders including tardive dyskinesia.
Chouinard G
J Clin Psychiatry; 2004; 65 Suppl 9():9-15. PubMed ID: 15189106
[TBL] [Abstract][Full Text] [Related]
17. Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia.
Vitek JL; Giroux M
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S131-40. PubMed ID: 10762140
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
Ganzini L; Casey DE; Hoffman WF; McCall AL
Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
[TBL] [Abstract][Full Text] [Related]
19. Electroconvulsive therapy in Parkinson's disease and other movement disorders.
Faber R; Trimble MR
Mov Disord; 1991; 6(4):293-303. PubMed ID: 1758447
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.
Jankovic J
Ann Neurol; 1982 Jan; 11(1):41-7. PubMed ID: 6460467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
